Angiotensin II signaling up-regulates the immediate early transcription factor ATF3 in the left but not the right atrium

Basic Research in Cardiology

Volumn 106, Issue 2, 2011, Pages 175-187

  Hasin, Tal ^a   Elhanani, Ofer ^a   Abassi, Zaid ^a   Hai, Tsonwin ^b   Aronheim, Ami ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Angiotensin; ATF3; Left atrium; Signal transduction

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ACTIVATING TRANSCRIPTION FACTOR 3; ANGIOTENSIN 1A RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; EPIDERMAL GROWTH FACTOR RECEPTOR; GEFITINIB; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; TRICIRIBINE; ANGIOTENSIN 1 RECEPTOR; ATF3 PROTEIN, HUMAN; ATF3 PROTEIN, MOUSE;

ADRENERGIC STIMULATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE INDUCTION; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HEART RIGHT ATRIUM; HORMONAL REGULATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PATHOGENESIS; PROTEIN TARGETING; RAT; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; C57BL MOUSE; CELL STRAIN HEK293; HEART ATRIUM; HEART MUSCLE; HUMAN; MALE; METABOLISM; WISTAR RAT;

ACTIVATING TRANSCRIPTION FACTOR 3; ANGIOTENSIN II; ANIMALS; HEART ATRIA; HEK293 CELLS; HUMANS; MALE; MICE; MICE, INBRED C57BL; MYOCARDIUM; RATS; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 79957894843     PISSN: 03008428     EISSN: 14351803     Source Type: Journal    
DOI: 10.1007/s00395-010-0145-9     Document Type: Article

References (49)

1. AbdAlla S, Lother H, Abdel-tawab AM, Quitterer U (2001) The angiotensin II AT2 receptor is an AT1 receptor antagonist. J Biol Chem 276:39721-39726. doi:10.1074/jbc.M105253200M10525 3200
2. Aronheim A, Zandi E, Hennemann H, Elledge S, Karin M (1997) Isolation of an AP-1 repressor by a novel method for detecting protein-protein interactions. Mol Cell Biol 17:3094-3102 (Pubitemid 27215024)
3. Auger-Messier M, Turgeon ES, Leduc R, Escher E, Guillemette G (2005) The constitutively active N111G-AT1 receptor for angiotensin II modifies the morphology and cytoskeletal organization of HEK-293 cells. Exp Cell Res 308:188-195. doi: 10.1016/j.yexcr.2005.04.015 (Pubitemid 40984773)
4. Boldt A, Scholl A, Garbade J, Resetar ME, Mohr FW, Gummert JF, Dhein S (2006) ACE-inhibitor treatment attenuates atrial structural remodeling in patients with lone chronic atrial fibrillation. Basic Res Cardiol 101:261-267. doi:10.1007/s00395- 005-0571-2 (Pubitemid 44093267)
5. Braunwald E (1997) Shattuck lecture-cardiovascular medicine at the turn of the millennium: triumphs, concerns, and opportunities. N Engl J Med 337:1360-1369. doi:10.1056/NEJM 199711063371906 (Pubitemid 27467771)
6. Burstein B, Libby E, Calderone A, Nattel S (2008) Differential behaviors of atrial versus ventricular fibroblasts: a potential role for platelet-derived growth factor in atrial-ventricular remodeling differences. Circulation 117:1630-1641. doi:10.1161/ CIRCULATIONAHA.107.748053 (Pubitemid 351482606)
7. Casaclang-Verzosa G, Gersh BJ, Tsang TS (2008) Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation. J Am Coll Cardiol 51:1-11. doi:10.1016/j.jacc.2007.09.026
8. Chen BPC, Wolfgang CD, Hai T (1996) Analysis of ATF3, a transcription factor induced by physiological stresses and modulated by gadd153/Chop. Mol Cell Biol 16:1157-1168 (Pubitemid 26061687)
9. Cornelius T, Holmer SR, Muller FU, Riegger GA, Schunkert H (1997) Regulation of the rat atrial natriuretic peptide gene after acute imposition of left ventricular pressure overload. Hypertension 30:1348-1355 (Pubitemid 27528074)
10. D'Amore A, Black MJ, Thomas WG (2005) The angiotensin II type 2 receptor causes constitutive growth of cardiomyocytes and does not antagonize angiotensin II type 1 receptor-mediated hypertrophy. Hypertension 46:1347-1354. doi:10.1161/01.HYP. 0000193504.51489.cf (Pubitemid 43189734)
11. Disertori M, Latini R, Barlera S, Franzosi MG, Staszewsky L, Maggioni AP, Lucci D, Di Pasquale G, Tognoni G (2009) Valsartan for prevention of recurrent atrial fibrillation. N Eng J Med 360:1606-1617. doi:10.1056/NEJMoa0805710
12. Fentzke RC, Korcarz CE, Lang RM, Lin H, Leiden JM (1998) Dilated cardiomyopathy in transgenic mice expressing a dominant- negative CREB transcription factor in the heart. J Clin Invest 101:2415-2426. doi:10.1172/JCI2950 (Pubitemid 28270436)
13. Frey N, Olson EN (2003) Cardiac hypertrophy: the good, the bad, and the ugly. Annu Rev Physiol 65:45-79 (Pubitemid 38249147)
14. Gao MH, Tang T, Guo T, Sun SQ, Feramisco JR, Hammond HK (2004) Adenylyl cyclase type VI gene transfer reduces phospholamban expression in cardiac myocytes via activating transcription factor 3. J Biol Chem 279:38797-38802. doi:10.1074/ jbc.M405701200M405701200 (Pubitemid 39296038)
15. Gillis AM (2009) Angiotensin-receptor blockers for prevention of atrial fibrillation-a matter of timing or target? N Engl J Med 360:1669-1671. doi:10.1056/NEJMe0901602
16. Hai T (2006) The ATF transcription factors in cellular adaptive responses. In: Ma J (ed) Gene expression and regulation. Higher Education Press, Beijing; Springer, New York, pp 329-340
17. Hai T, Hartman MG (2001) The molecular biology and nomenclature of the activating transcription factor/cAMP responsive element binding family of transcription factors: activating transcription factor proteins and homeostasis. Gene 273:1-11 (Pubitemid 32718721)
18. Hai T, Wolfgang CD, Marsee DK, Allen AE, Sivaprasad U (1999) ATF3 and stress responses. Gene Express 7:321-335 (Pubitemid 29372076)
19. Hein L, Barsh GS, Pratt RE, Dzau VJ, Kobilka BK (1995) Behavioural and cardiovascular effects of disrupting the angiotensin II type-2 receptor in mice. Nature 377:744-747. doi: 10.1038/377744a0
20. Hein L, Stevens ME, Barsh GS, Pratt RE, Kobilka BK, Dzau VJ (1997) Overexpression of angiotensin AT1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block. Proc Natl Acad Sci USA 94:6391-6396 (Pubitemid 27270695)
21. Hilfiker-Kleiner D, Hilfiker A, Kaminski K, Schaefer A, Park JK, Michel K, Quint A, Yaniv M, Weitzman JB, Drexler H (2005) Lack of JunD promotes pressure overload-induced apoptosis, hypertrophic growth, and angiogenesis in the heart. Circulation 112:1470-1477. doi:10.1161/CIRCULATIONAHA.104.518472 (Pubitemid 41291772)
22. Ichihara S, Senbonmatsu T, Price E Jr, Ichiki T, Gaffney FA, Inagami T (2001) Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension. Circulation 104:346-351 (Pubitemid 32666959)
23. Ichiki T, Labosky PA, Shiota C, Okuyama S, Imagawa Y, Fogo A, Niimura F, Ichikawa I, Hogan BL, Inagami T (1995) Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor. Nature 377:748-750. doi: 10.1038/377748a0
24. Jin C, Ugai H, Song J, Murata T, Nili F, Sun K, Horikoshi M, Yokoyama KK (2001) Identification of mouse Jun dimerization protein 2 as a novel repressor of ATF-2. FEBS Lett 489:34-41 (Pubitemid 32176001)
25. Kehat I, Hasin T, Aronheim A (2006) The role of basic leucine zipper protein-mediated transcription in physiological and pathological myocardial hypertrophy. Ann N Y Acad Sci 1080:97-109. doi:10.1196/annals.1380.009 (Pubitemid 44955416)
26. Kehat I, Heinrich R, Ben-Izhak O, Miyazaki H, Gutkind JS, Aronheim A (2006) Inhibition of basic leucine zipper transcription is a major mediator of atrial dilatation. Cardiovasc Res 70:543-554. doi:10.1016/j.cardiores.2006.02. 018
27. Kovacic-Milivojevic B, Gardner DG (1995) Fra-1, a Fos gene family member that activates atrial natriuretic peptide gene transcription. Hypertension 25:679-682
28. Li Y, Li WM, Gong YT, Li BX, Liu W, Han W, Dong D, Sheng L, Xue JY, Zhang L, Chu S, Yang BF (2007) The effects of cilazapril and valsartan on the mRNA and protein expressions of atrial calpains and atrial structural remodeling in atrial fibrillation dogs. Basic Res Cardiol 102:245-256. doi:10.1007/s00395- 007-0641-8 (Pubitemid 46566279)
29. Mehta PK, Griendling KK (2007) Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol 292:C82-C97. doi:10.1152/ajpcell.00287. 2006 (Pubitemid 46127306)
30. Molkentin JD, Dorn GW 2nd (2001) Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annu Rev Physiol 63:391-426. doi:10.1146/annurev. physiol.63.1.39163/1/391 (Pubitemid 32304323)
31. Nadruz W Jr, Kobarg CB, Kobarg J, Franchini KG (2004) c-Jun is regulated by combination of enhanced expression and phosphorylation in acute-overloaded rat heart. Am J Physiol Heart Circ Physiol 286:H760-H767. doi:10.1152/ajpheart. 00430. 200300430.2003 (Pubitemid 38140359)
32. Nakajima M, Hutchinson HG, Fujinaga M, Hayashida W, Morishita R, Zhang L, Horiuchi M, Pratt RE, Dzau VJ (1995) The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: gain-of-function study using gene transfer. Proc Natl Acad Sci USA 92:10663-10667
33. Okamoto Y, Chaves A, Chen J, Kelley R, Jones K, Weed HG, Gardner KL, Gangi L, Yamaguchi M, Klomkleaw W, Nakayama T, Hamlin RL, Carnes C, Altschuld R, Bauer J, Hai T (2001) Transgenic mice with cardiac-specific expression of activating transcription factor 3, a stress-inducible gene, have conduction abnormalities and contractile dysfunction. Am J Pathol 159:639-650 (Pubitemid 32751094)
34. Rakesh K, Yoo B, Kim IM, Salazar N, Kim KS, Rockman HA (2010) Beta-Arrestin-biased agonism of the angiotensin receptor induced by mechanical stress. Sci Signal 3:ra46 doi: 3/125/ra46 [pii] 10.1126/scisignal.2000769
35. Reudelhuber TL (2005) The continuing saga of the AT2 receptor: a case of the good, the bad, and the innocuous. Hypertension 46:1261-1262. doi:10.1161/01.HYP.0000193498.07087.83 (Pubitemid 43189720)
36. Rockman HA, Ross RS, Harris AN, Knowlton KU, Steinhelper ME, Field LJ, Ross J Jr, Chien KR (1991) Segregation of atrialspecific and inducible expression of an atrial natriuretic factor transgene in an in vivo murine model of cardiac hypertrophy. Proc Natl Acad Sci USA 88:8277-8281 (Pubitemid 21915339)
37. Saygili E, Rana OR, Meyer C, Gemein C, Andrzejewski MG, Ludwig A, Weber C, Schotten U, Kruttgen A, Weis J, Schwinger RH, Mischke K, Rassaf T, Kelm M, Schauerte P (2009) The angiotensin-calcineurin-NFAT pathway mediates stretch-induced up-regulation of matrix metalloproteinases-2/-9 in atrial myocytes. Basic Res Cardiol 104:435-448. doi:10.1007/s00395-008- 0772-6
38. Scow DT, Smith EG, Shaughnessy AF (2003) Combination therapy with ACE inhibitors and angiotensin-receptor blockers in heart failure. Am Fam Phys 68:1795-1798 (Pubitemid 37385773)
39. Shah BH, Catt KJ (2003) A central role of EGF receptor transactivation in angiotensin II-induced cardiac hypertrophy. Trends Pharmacol Sci 24:239-244 (Pubitemid 36588872)
40. Shaulian E, Karin M (2002) AP-1 as a regulator of cell life and death. N Cell Biol 4:E131-E136. doi:10.1038/ncb0502-e131ncb 0502-e131 (Pubitemid 34521026)
41. Smith NJ, Chan HW, Osborne JE, Thomas WG, Hannan RD (2004) Hijacking epidermal growth factor receptors by angiotensin II: new possibilities for understanding and treating cardiac hypertrophy. Cell Mol Life Sci 61:2695-2703. doi:10.1007/ s00018-004-4244-3 (Pubitemid 40022430)
42. Stoll M, Steckelings UM, Paul M, Bottari SP, Metzger R, Unger T (1995) The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J Clin Invest 95:651-657. doi:10.1172/JCI117710
43. Tabibiazar R, Wagner RA, Liao A, Quertermous T (2003) Transcriptional profiling of the heart reveals chamber-specific gene expression patterns. Circ Res 93:1193-1201. doi:10.1161/ 01.RES.0000103171.42654.DD01.RES.0000103171. 42654.DD (Pubitemid 37543059)
44. Timmermans PB, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, Lee RJ, Wexler RR, Saye JA, Smith RD (1993) Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 45:205-251 (Pubitemid 23191415)
45. Wachtell K, Lehto M, Gerdts E, Olsen MH, Hornestam B, Dahlof B, Ibsen H, Julius S, Kjeldsen SE, Lindholm LH, Nieminen MS, Devereux RB (2005) Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: the losartan intervention for end point reduction in hypertension (LIFE) study. J Am Coll Cardiol 45:712-719. doi: 10.1016/j.jacc.2004.10.068 (Pubitemid 40282586)
46. Wattigney WA, Mensah GA, Croft JB (2003) Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention. Circulation 108:711-716. doi:10.1161/01.CIR.0000083722.42033.0A01.CIR. 0000083722.42033.0A (Pubitemid 36999256)
47. Wharton J, Morgan K, Rutherford RA, Catravas JD, Chester A, Whitehead BF, De Leval MR, Yacoub MH, Polak JM (1998) Differential distribution of angiotensin AT2 receptors in the normal and failing human heart. J Pharmacol Exp Ther 284:323-336 (Pubitemid 28109563)
48. Xiao HD, Fuchs S, Campbell DJ, Lewis W, Dudley SC Jr, Kasi VS, Hoit BD, Keshelava G, Zhao H, Capecchi MR, Bernstein KE (2004) Mice with cardiac-restricted angiotensin-converting enzyme (ACE) have atrial enlargement, cardiac arrhythmia, and sudden death. Am J Pathol 165:1019-1032 (Pubitemid 39129307)
49. Zou Y, Akazawa H, Qin Y, Sano M, Takano H, Minamino T, Makita N, Iwanaga K, Zhu W, Kudoh S, Toko H, Tamura K, Kihara M, Nagai T, Fukamizu A, Umemura S, Iiri T, Fujita T, Komuro I (2004) Mechanical stress activates angiotensin II type 1 receptor without the involvement of angiotensin II. N cell Biol 6:499-506. doi:10.1038/ncb1137ncb1137 (Pubitemid 38786592)